Conferencia. Terapia de reemplazo renal —TRR—

Clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S17-31.

Reiser IW, Porush JG. Evaluation of Renal Function. In: Massry SG and Glassock RJ. eds. Textbook of Nephrology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 1793-1801

Bailey JL, Mitch WE. Pathophysiology of Uremia. In: Brenner BM. Ed. The Kidney, 6' ed. Philadelphia: W.B. Saunders, 2000: 2059 2078.

Sarnak MJ, Levey AS. Progression of Renal lnsufficiency. Methods of Assessment. In: Massry SG and Glassock RJ. Eds.Textbook of Nephrology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 1203-1210.

Abbate M, Remuzzi G. Progression of Renal lnsufficiency. Mechanisms. In: Massry SG and Glassock RJ. Eds.Textbook of Nephrology. 411' ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 1210-1217.

Mackenzie HS, Taal MW, Luyckx VA, Brenner BM. Adaptation to Nephron Loss. In: Brenner BM. Ed. The Kidney, 6th ed. Philadelphia: W.B. Saunders, 2000: 1901-1942.

Rose, BD. Secuandary Factors and Progression of Renal Failure. En ( CD - ROM ) Washington: Uptodate, 2002. Vol 11, No. 1.

Holley,JL. Nephrologists as primary care providers: A review of the issues. Am Jkidney Dis1998; 4: 574.

Nath, KA. The tubulointerstisium in progressive renal disease (Editorial). Kidney Int 1998; 54: 992.

Noronha, IL, Fujihara, CK, Zatz, R. The inflammary component in progresisive renal disease are interventions possible?. Nephrol Dial Transplant 2002; 17 :363.

Massy, ZA, Khoa, TN, Lacour, B, et al. Dyslipidaemia and the progression of renal disese in chronic renal failure patients. Nephrol Dial Transplant 1999; 14:2392.

D'achiardi R, Ariza M. Insuficiencia Renal Crónica.. En: Borrero J, Montero O Eds.Fundamentos de Medicina, Nefrología. 40 ed. Medellín: CIB, 2003: 729-738.

Kopple JO. Nutritional Management. Chronic Renal Failure. In: Massry SG and Glassock RJ. Eds.Textbook of Nephrology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 1454- 1473.

NKF-DOQI guidelines: Anemia of Chronic Kidney Disease: III. 'ron Support: Guidelines 5 —10 Part I and II. Am J Kidney Dis 2001;37:S194-206.

NKF-DOQI guidelines: Anemia of Chronic Kidney Disease: IV. Administration of Epoetin: Guidelines 11-19. Am J Kidney Dis 2001;37:5207-211.

Goodman WG, Danovitch GM. Options for Patients with End-Stage Renal Disease. In: Danovitch GM. Ed. Handbook of Kidney Transplantation. 3th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 1-16.

Post TW, Rose BD. Overview of the Management of Chronic renal failure. En ( CD - ROM ) Washington: Uptodate, 2002. Vol 11, No. 1.

Hakim RM, Ismail N. lndications for lnitiation of Dialysis in Chronic Renal Failure. En ( CD - ROM ) Washington: Uptodate, 2002. Vol 11, No. 1.

NKF-DOQI guidelines: PD adequacy: I. lnitiation of Dialysis: Guidelines 1-2. Am J Kidney Dis 1997:30(35upp2): S67-S136.

Lacson EK, Jr, Owen WF,Jr. lndividualized Hemodialysis Treatment Regimens.. In: Massry SG and Glassock RJ. eds. Textbook of Nephrology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 1502-1505.

Gokal R. Techniques, lndications, and Complications of Peritoneal Dialisys. In: Massry SG and Glassock RJ. eds. Textbook of Nephrology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 1532-1542.

Katznelson S, Takemoto SK, Cecka JM. Histocompatibility Testing, Crossmatching and, Allocation of Cadaveric Kidney Transplants. In: Danovitch GM. Ed. Handbook of Kidney Transplantation. 3th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 39-61.

Danovitch GM. lmmunosuppressive Medications and Protocols for Kidney Transplantation. In: Danovitch GM. Ed. Handbook of Kidney Transplantation. 3th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 1-16.

Mejía G. Trasplante Renal. En: Borrero J, Montero O Eds. Fundamentos de Medicina, Nefrología. 40 ed. Medellín: CIB, 2003: 787-806.